NCT00140725 Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) Status COMPLETED Phase PHASE3
NCT00140712 Ropinirole Tablets In Young Patients With Restless Legs Syndrome Status COMPLETED Phase PHASE1
NCT00140686 To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines Status COMPLETED Phase PHASE3
NCT00140673 A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. Status COMPLETED Phase PHASE3
NCT00139347 Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants Status COMPLETED Phase PHASE3
NCT00139334 A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh Status COMPLETED Phase PHASE2
NCT00139113 Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children Status COMPLETED Phase PHASE4
NCT00137930 Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis Status COMPLETED Phase PHASE2
NCT00137917 Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs Status COMPLETED Phase PHASE2
NCT00136604 Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m Status COMPLETED Phase PHASE3
NCT00136578 Ispinesib In Combination With Carboplatin In Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00136383 Comparing Paroxetine and Duloxetine on Cardiovascular Measures Status COMPLETED Phase PHASE2/PHASE3
NCT00135577 Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects Status COMPLETED Phase PHASE2
NCT00135564 Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitecâ„¢ in Healthy Toddlers Status COMPLETED Phase PHASE2
NCT00135486 Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants Status COMPLETED Phase PHASE2
NCT00135200 Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma Status COMPLETED Phase PHASE2